Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia

M Meier, M L den Boer, J P P Meijerink, M J C Broekhuis, M M C J Passier, E R van Wering, G E Janka-Schaub, R Pieters

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)


The T-lineage phenotype of childhood acute lymphoblastic leukaemia (ALL) is associated with an increased relapse-risk and in vitro resistance to drugs as compared to a precursor B phenotype. Antiapoptotic isoforms of p73 that lack part of the transactivation (TA) domain (DeltaTA-p73, i.e. p73Deltaex2, p73Deltaex3, p73Deltaex2/3 and DeltaN-p73) may cause resistance to anticancer agents through inhibition of p53 and/or proapoptotic p73 family members (TA-p73). We demonstrate in our study that the expression of total p73 mRNA was higher in childhood T-ALL compared to controls (P=0.004). In T-ALL, the relative contribution of antiapoptotic DeltaTA-p73 (88%) was larger than of proapoptotic TA-p73 (12%). Leukaemic cells of T-ALL patients expressing higher levels of antiapoptotic p73 were more resistant to the DNA-damaging drug daunorubicin compared to cells of patients with low or negative expression or these isoforms (P(trend)=0.045). Interestingly, p73Deltaex2 was the most abundantly expressed antiapoptotic isoform in daunorubicin-resistant patient cells (44% of total p73). No association was found between high expression of proapoptotic TA-p73 or antiapoptotic DeltaTA-p73 and relapse-risk. Our results suggest that childhood T-ALL is associated with a high expression of DeltaTA-p73. These isoforms may play a role in cellular resistance to DNA-damaging drugs in children at initial diagnosis of T-ALL.

Original languageEnglish
Pages (from-to)1377-84
Number of pages8
Issue number8
Publication statusPublished - Aug 2006
Externally publishedYes


  • Adolescent
  • Cell Lineage
  • Child
  • Child, Preschool
  • DNA Methylation
  • DNA-Binding Proteins/genetics
  • Drug Resistance, Neoplasm
  • Genes, Tumor Suppressor
  • Humans
  • Infant
  • Leukemia-Lymphoma, Adult T-Cell/drug therapy
  • Loss of Heterozygosity
  • Nuclear Proteins/genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
  • Protein Isoforms
  • RNA, Messenger/analysis
  • Tumor Protein p73
  • Tumor Suppressor Proteins


Dive into the research topics of 'Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia'. Together they form a unique fingerprint.

Cite this